Erudio Bio provides the measurement and software stack necessary for binding-aware artificial intelligence in drug discovery. Their Versatile Smart Assay converts molecular interactions into kinetics-resolved binding labels that train and validate AI models to accurately rank true drug candidates. This data and software layer allows research teams to reduce wet-lab cycles and de-risk candidates earlier in the preclinical development process.
Funding
Funding not disclosed
Founders
Product
Problem
Current multiplexed biomarker testing methods often struggle with accuracy due to cross-reactivity and non-specific binding, leading to potential false positives and delayed disease detection. This limitation impacts the precision of diagnoses and the efficiency of biopharmaceutical drug development pipelines.
Solution
Erudio Bio offers a semiconductor-based multiplexed instrument platform, the Versatile Smart Assay (VSA), designed for comprehensive biomarker analysis from a single biological sample. The platform leverages patented dynamic force spectroscopy to measure the precise binding strength of biomarkers to antibodies, thereby filtering out non-specific interactions and significantly enhancing assay accuracy. This technology enables earlier and more precise disease identification, supporting improved patient outcomes and streamlining the drug development process. The VSA platform is engineered to generate robust datasets, facilitating advanced analytics for knowledge discovery.
Target Audience
The primary target audience includes clinical diagnostic laboratories, healthcare providers requiring precise diagnostic tools, and biotechnology companies engaged in drug discovery and development.
Features
- Semiconductor-based multiplexed assay platform for simultaneous detection of multiple biomarkers.
- Patented dynamic force spectroscopy technology for measuring biomarker-antibody binding strength, ensuring high specificity.
- Reduced false positive rates through precise measurement of molecular interactions.
- Capability to analyze a single biological sample for comprehensive biomarker profiling.
- Designed to facilitate early disease detection and support biopharmaceutical R&D.
- Generates extensive biological data suitable for AI and machine learning applications.